1990
DOI: 10.1016/0304-3940(90)90138-y
|View full text |Cite
|
Sign up to set email alerts
|

Altered hexokinase activity in skin cultured fibroblasts and leukocytes from Alzheimer's disease patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
13
1

Year Published

1994
1994
2024
2024

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 25 publications
(14 citation statements)
references
References 10 publications
0
13
1
Order By: Relevance
“…Our findings are in accordance with the findings of Mortilla and Sorbi [28] and Pomara et al [9], who used clinical and methodological criteria identi cal to our study. Our data however are in contrast with the results of Sorbi et al [23], who reported a decreased HK activity in familial AD leukocytes and fibroblasts. The difference is likely due to a difference in Sorbi's definition of familial AD (autosomal dominant) which differs from ours (affected first-degree relative).…”
Section: Discussioncontrasting
confidence: 57%
See 1 more Smart Citation
“…Our findings are in accordance with the findings of Mortilla and Sorbi [28] and Pomara et al [9], who used clinical and methodological criteria identi cal to our study. Our data however are in contrast with the results of Sorbi et al [23], who reported a decreased HK activity in familial AD leukocytes and fibroblasts. The difference is likely due to a difference in Sorbi's definition of familial AD (autosomal dominant) which differs from ours (affected first-degree relative).…”
Section: Discussioncontrasting
confidence: 57%
“…Other authors have reported but not commented on this trend. The study of Pomara et al [9] of HK in lymphocytes of AD patients as well as the work of Sorbi et al [23] in fibroblasts and leukocytes found a similar pattern where the AD group averaged a SD 42% higher than controls. This trend was also present when HK was measured in brain tissue [21], The cause of higher HK activity and larger variance in the old and AD is unclear.…”
Section: Discussionmentioning
confidence: 63%
“…Hexokinase interaction with the mitochondrial VDAC also plays an important role in preventing mitochondria-mediated apoptosis and promoting cell survival in neurons and other cell types [52]–[54]. AD patients exhibit declined hexokinase activity in the brain, cerebral microvessel, leukocytes and fibroblasts [55][57]. Previous studies have demonstrated that ovarian hormone loss led to compromised-brain hexokinase activity, whereas short-term estrogen treatment was efficacious to increase hexokinase activity in rat brains [12].…”
Section: Discussionmentioning
confidence: 99%
“…Type II hexokinasemitochondrial interactions were observed to promote tumor cell growth, and hexokinase has been suggested as the ideal target for therapeutic intervention (4,5). Modifications in the catalytic activity of hexokinase have been suggested to play a role in the pathogenesis of the Alzheimer's disease (6). Recently, it has been shown that hexokinase plays a role in sensing and maintaining the glucose levels and in signal transduction to regulate the expression of genes in plants (7,8).…”
mentioning
confidence: 99%